Greenwich LifeSciences, Inc. SEC filings GLSI

Greenwich LifeSciences, Inc. has 279 filings in SEC EDGAR's recent list, going back to Jan 27, 2020. Its latest annual report, Form ARS, was filed on Oct 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Dec 18, 2025 (shareholder vote results). The company's fiscal year ends on December 31.

Greenwich LifeSciences, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Oct 26, 2026 —
ARS Annual report to shareholders Oct 26, 2026 Dec 31, 2025
DEF 14A Proxy statement Oct 26, 2026 Oct 26, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
4 Insider transaction Jul 27, 2026 Jul 23, 2026
10-Q Quarterly report Jun 4, 2026 Mar 31, 2026
10-K Annual report Jun 1, 2026 Dec 31, 2025
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 2, 2026 Dec 30, 2025
4 Insider transaction Dec 19, 2025 Dec 18, 2025
8-K Current report
Shareholder vote results
Dec 18, 2025 Dec 18, 2025
4 Insider transaction Nov 28, 2025 Nov 25, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
ARS Annual report to shareholders Nov 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Nov 3, 2025 —
DEF 14A Proxy statement Nov 3, 2025 Nov 3, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Auditor change
Jul 24, 2025 Jul 19, 2025
10-Q Quarterly report May 20, 2025 Mar 31, 2025
NT 10-Q Filing May 15, 2025 Mar 31, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 22, 2025 Apr 17, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
4 Insider transaction Apr 8, 2025 Apr 7, 2025
4 Insider transaction Apr 7, 2025 Apr 4, 2025
NT 10-K Filing Mar 31, 2025 Dec 31, 2024
4 Insider transaction Jan 13, 2025 Jan 10, 2025
4 Insider transaction Jan 8, 2025 Jan 6, 2025
4 Insider transaction Jan 7, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Dec 27, 2024 Dec 24, 2024
4 Insider transaction Dec 27, 2024 Dec 24, 2024
4 Insider transaction Dec 27, 2024 Dec 24, 2024
4 Insider transaction Dec 27, 2024 Dec 24, 2024
4 Insider transaction Dec 27, 2024 Dec 24, 2024
4 Insider transaction Dec 27, 2024 Dec 24, 2024
S-8 Employee stock plan registration Dec 20, 2024 —
8-K Current report
Shareholder vote results
Dec 19, 2024 Dec 19, 2024
4 Insider transaction Nov 25, 2024 Nov 21, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
DEFA14A Additional proxy material Nov 1, 2024 —
ARS Annual report to shareholders Nov 1, 2024 Dec 31, 2023
DEF 14A Proxy statement Nov 1, 2024 Nov 1, 2024
EFFECT Filing Oct 17, 2024 —
CORRESP Letter to the SEC Oct 15, 2024 —
UPLOAD Letter from the SEC Oct 11, 2024 —
S-3 Shelf registration Oct 7, 2024 —
4 Insider transaction Sep 30, 2024 Sep 26, 2024
4 Insider transaction Sep 16, 2024 Aug 12, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
4 Insider transaction Aug 8, 2024 Aug 6, 2024
4 Insider transaction Aug 7, 2024 Aug 5, 2024
4 Insider transaction Aug 5, 2024 Aug 2, 2024
4 Insider transaction Jul 24, 2024 Jul 23, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
D Filing Jun 18, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
10-Q Quarterly report May 20, 2024 Mar 31, 2024
NT 10-Q Filing May 15, 2024 Mar 31, 2024
10-K Annual report Apr 15, 2024 Dec 31, 2023
4 Insider transaction Apr 3, 2024 Apr 1, 2024
NT 10-K Filing Apr 1, 2024 Dec 31, 2023
4 Insider transaction Mar 26, 2024 Mar 22, 2024
4 Insider transaction Mar 22, 2024 Mar 20, 2024
4/A Filing Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Feb 21, 2024 Feb 16, 2024
8-K Current report
Auditor change
Feb 20, 2024 Feb 14, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
8-K Current report
Other events
Feb 14, 2024 Feb 14, 2024
8-K Current report
Shareholder vote results
Dec 15, 2023 Dec 15, 2023
4 Insider transaction Nov 14, 2023 Nov 10, 2023
4 Insider transaction Nov 7, 2023 Nov 3, 2023
4 Insider transaction Oct 31, 2023 Oct 27, 2023
4 Insider transaction Oct 30, 2023 Oct 26, 2023
4 Insider transaction Oct 27, 2023 Oct 25, 2023
DEFA14A Additional proxy material Oct 25, 2023 —
ARS Annual report to shareholders Oct 25, 2023 Dec 31, 2022
DEF 14A Proxy statement Oct 25, 2023 Oct 24, 2023
10-Q Quarterly report Oct 19, 2023 Sep 30, 2023
4 Insider transaction Oct 12, 2023 Oct 10, 2023
4 Insider transaction Oct 5, 2023 Oct 4, 2023
4 Insider transaction Sep 28, 2023 Sep 26, 2023
4 Insider transaction Sep 21, 2023 Sep 19, 2023
4 Insider transaction Sep 13, 2023 Sep 11, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
10-Q Quarterly report Aug 21, 2023 Jun 30, 2023
NT 10-Q Filing Aug 14, 2023 Jun 30, 2023
4 Insider transaction Aug 8, 2023 Aug 4, 2023
4 Insider transaction Jul 25, 2023 Jul 21, 2023
4 Insider transaction Jul 17, 2023 Jul 13, 2023
10-Q Quarterly report May 22, 2023 Mar 31, 2023
4 Insider transaction May 18, 2023 May 17, 2023
NT 10-Q Filing May 15, 2023 Mar 31, 2023
4 Insider transaction May 2, 2023 Apr 28, 2023
4 Insider transaction Apr 21, 2023 Apr 19, 2023
4 Insider transaction Apr 20, 2023 Apr 18, 2023
8-K Current report
Other events
Apr 13, 2023 Apr 13, 2023
4 Insider transaction Apr 12, 2023 Apr 11, 2023
4 Insider transaction Apr 12, 2023 Apr 11, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
4 Insider transaction Mar 16, 2023 Mar 15, 2023
4 Insider transaction Mar 13, 2023 Mar 10, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
4 Insider transaction Feb 28, 2023 Feb 24, 2023
4 Insider transaction Feb 22, 2023 Feb 17, 2023
4 Insider transaction Feb 14, 2023 Feb 10, 2023
4 Insider transaction Feb 7, 2023 Feb 3, 2023
4 Insider transaction Jan 31, 2023 Jan 27, 2023
4 Insider transaction Jan 30, 2023 Jan 27, 2023
4 Insider transaction Jan 24, 2023 Jan 20, 2023
4 Insider transaction Jan 17, 2023 Jan 13, 2023
4 Insider transaction Jan 10, 2023 Jan 6, 2023
4 Insider transaction Jan 3, 2023 Dec 29, 2022
4 Insider transaction Dec 20, 2022 Dec 16, 2022
4 Insider transaction Dec 20, 2022 Dec 16, 2022
4 Insider transaction Dec 13, 2022 Dec 9, 2022
8-K Current report
Shareholder vote results
Dec 9, 2022 Dec 9, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
4 Insider transaction Dec 6, 2022 Dec 2, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
4 Insider transaction Nov 4, 2022 Nov 2, 2022
DEFA14A Additional proxy material Oct 19, 2022 —
DEF 14A Proxy statement Oct 19, 2022 Oct 19, 2022
4 Insider transaction Oct 17, 2022 Oct 14, 2022
4 Insider transaction Oct 11, 2022 Oct 7, 2022
4 Insider transaction Oct 4, 2022 Sep 30, 2022
4 Insider transaction Oct 3, 2022 Sep 29, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Material agreement
Jul 12, 2022 Jul 12, 2022
424B5 Prospectus supplement Jul 12, 2022 —
8-K Current report
Other events
Jul 12, 2022 Jul 12, 2022
8-K Current report
Other events
Jul 11, 2022 Jul 11, 2022
S-8 Employee stock plan registration Jul 5, 2022 —
4 Insider transaction Jun 27, 2022 Jun 24, 2022
10-K/A Amended annual report Jun 24, 2022 Dec 31, 2021
4 Insider transaction Jun 24, 2022 Jun 22, 2022
4 Insider transaction Jun 24, 2022 Jun 22, 2022
4 Insider transaction Jun 24, 2022 Jun 22, 2022
4 Insider transaction Jun 24, 2022 Jun 22, 2022
4 Insider transaction Jun 24, 2022 Jun 22, 2022
4 Insider transaction Jun 24, 2022 Jun 22, 2022
SC 13G Ownership over 5% (passive) Jun 22, 2022 —
4 Insider transaction Jun 17, 2022 Jun 16, 2022
4 Insider transaction Jun 15, 2022 Jun 14, 2022
4 Insider transaction Jun 13, 2022 Jun 10, 2022
4 Insider transaction Jun 10, 2022 Jun 9, 2022
4 Insider transaction Jun 8, 2022 Jun 7, 2022
4 Insider transaction Jun 6, 2022 Jun 3, 2022
4 Insider transaction Jun 3, 2022 Jun 2, 2022
10-Q Quarterly report May 20, 2022 Mar 31, 2022
NT 10-Q Filing May 17, 2022 Mar 31, 2022
4 Insider transaction Apr 26, 2022 Apr 25, 2022
4 Insider transaction Apr 22, 2022 Apr 21, 2022
4 Insider transaction Apr 21, 2022 Apr 19, 2022
4 Insider transaction Apr 20, 2022 Apr 19, 2022
EFFECT Filing Apr 6, 2022 —
CORRESP Letter to the SEC Apr 4, 2022 —
S-3/A Filing Apr 1, 2022 —
UPLOAD Letter from the SEC Mar 31, 2022 —
S-3 Shelf registration Mar 25, 2022 —
10-K Annual report Mar 21, 2022 Dec 31, 2021
4 Insider transaction Feb 14, 2022 Feb 11, 2022
4 Insider transaction Feb 8, 2022 Feb 4, 2022
4 Insider transaction Feb 1, 2022 Jan 31, 2022
4 Insider transaction Jan 24, 2022 Jan 21, 2022
4 Insider transaction Jan 24, 2022 Jan 21, 2022
4 Insider transaction Jan 19, 2022 Jan 18, 2022
4 Insider transaction Jan 18, 2022 Jan 13, 2022
4 Insider transaction Jan 14, 2022 Jan 13, 2022
4 Insider transaction Jan 14, 2022 Jan 13, 2022
3 Initial insider ownership Jan 11, 2022 Dec 20, 2021
4 Insider transaction Jan 4, 2022 Jan 3, 2022
4 Insider transaction Dec 16, 2021 Dec 14, 2021
4 Insider transaction Dec 16, 2021 Dec 14, 2021
4 Insider transaction Dec 16, 2021 Dec 14, 2021
8-K Current report
Shareholder vote results
Dec 15, 2021 Dec 15, 2021
8-K Current report
Other events
Dec 13, 2021 Dec 9, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Regulation FD disclosure
Nov 10, 2021 Nov 9, 2021
DEFA14A Additional proxy material Oct 20, 2021 —
DEF 14A Proxy statement Oct 19, 2021 Oct 19, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Other events
Jun 10, 2021 Jun 8, 2021
8-K Current report
Other events
Jun 9, 2021 Jun 7, 2021
10-Q Quarterly report May 20, 2021 Mar 31, 2021
NT 10-Q Filing May 17, 2021 Mar 31, 2021
8-K Current report
Other events
Apr 20, 2021 Apr 19, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GLSI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Stafford, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1799788

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.